Date:5/3/2012

Margin1.64 %1.47 %Segment Profit Margin3.51 %4.46 %Refer to definitions for an explanation of calculations.Total consolidated revenue for the nine months ended March 31, 2012 was $80,788 million, which included total segment revenue of $80,801 million and Corporate revenue of $(13) million. Total consolidated revenue for the nine months ended March 31, 2011 was $75,881 million, which included total segment revenue of $75,896 million and Corporate revenue of $(15) million. Corporate revenue consists primarily of elimination of inter-segment revenue.Total consolidated operating earnings for the nine months ended March 31, 2012 were $1,388 million, which included total segment profit of $1,457 million and Corporate costs of $(69) million. Total consolidated operating earnings for the nine months ended March 31, 2011 were $1,155 million, which included total segment profit of $1,315 million and Corporate costs of $(160) million. Corporate includes, among other things, restructuring and employee severance, acquisition-related costs (including amortization of acquisition-related intangible assets and changes in the fair value of contingent consideration obligations), impairments and loss on disposal of assets, litigation (recoveries)/charges, net and certain investment spending that are not allocated to the segments.Schedule 8CARDINAL HEALTH, INC. AND SUBSIDIARIESSCHEDULE OF NOTABLE ITEMSThird QuarterYear-to-Date(in millions, except per Common Share amounts)2012201120122011Restructuring and Employee SeveranceRestructuring and employee severance$   (7.1)$   (6.2)$ (12.2)$
(10.6)Tax benefit2.72.44.64.1Restructuring and employee severance, net of tax$   (4.4)$   (3.8)$   (7.6)$
(6.5)Decrease to diluted EPS from continuing operations$ (0.01)$ (0.01)$ (0.02)$
(0.02)Acquisition-Related CostsAmortization of acquisition-related intangible assets$ (20.4)$ (27.9)$ (57.9)$
(53.4)Tax benefit7.27.420.713.2Amortizat
'/>"/>

SOURCE Cardinal Health, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine technology :

1. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
2. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
3. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
4. Cardinal Health Completes Enturia Acquisition
5. Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
6. AmeriCares Honors Cardinal Health with Power of Partnership Award
7. Cardinal Health Helps Hospitals Save More Than $20 Million In Pharmaceutical Costs; Connect Low-Income Patients With Affordable Medications
8. Cardinal Health Executives to Speak at Two Investor Events in January
9. Cardinal Health Names Carrie Cox to Board of Directors
10. Cardinal Health Raises Quarterly Dividend By 11 Percent
11. Cardinal Health Supports ACRIN Clinical Trials Evaluating Oncologic Biotracers